Literature DB >> 28137882

E3 ubiquitin ligase Mule targets β-catenin under conditions of hyperactive Wnt signaling.

Carmen Dominguez-Brauer1, Rahima Khatun2, Andrew J Elia1, Kelsie L Thu1, Parameswaran Ramachandran1, Shakiba P Baniasadi1, Zhenyue Hao1, Lisa D Jones1, Jillian Haight1, Yi Sheng3, Tak W Mak4.   

Abstract

Wnt signaling, named after the secreted proteins that bind to cell surface receptors to activate the pathway, plays critical roles both in embryonic development and the maintenance of homeostasis in many adult tissues. Two particularly important cellular programs orchestrated by Wnt signaling are proliferation and stem cell self-renewal. Constitutive activation of the Wnt pathway resulting from mutation or improper modulation of pathway components contributes to cancer development in various tissues. Colon cancers frequently bear inactivating mutations of the adenomatous polyposis coli (APC) gene, whose product is an important component of the destruction complex that regulates β-catenin levels. Stabilization and nuclear localization of β-catenin result in the expression of a panel of Wnt target genes. We previously showed that Mule/Huwe1/Arf-BP1 (Mule) controls murine intestinal stem and progenitor cell proliferation by modulating the Wnt pathway via c-Myc. Here we extend our investigation of Mule's influence on oncogenesis by showing that Mule interacts directly with β-catenin and targets it for degradation under conditions of hyperactive Wnt signaling. Our findings suggest that Mule uses various mechanisms to fine-tune the Wnt pathway and provides multiple safeguards against tumorigenesis.

Entities:  

Keywords:  Mule; Wnt signaling; colorectal cancer; stem cells; β-catenin

Mesh:

Substances:

Year:  2017        PMID: 28137882      PMCID: PMC5320996          DOI: 10.1073/pnas.1621355114

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Wnt signaling and cancer.

Authors:  P Polakis
Journal:  Genes Dev       Date:  2000-08-01       Impact factor: 11.361

2.  Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids.

Authors:  Mami Matano; Shoichi Date; Mariko Shimokawa; Ai Takano; Masayuki Fujii; Yuki Ohta; Toshiaki Watanabe; Takanori Kanai; Toshiro Sato
Journal:  Nat Med       Date:  2015-02-23       Impact factor: 53.440

3.  Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene.

Authors:  L K Su; K W Kinzler; B Vogelstein; A C Preisinger; A R Moser; C Luongo; K A Gould; W F Dove
Journal:  Science       Date:  1992-05-01       Impact factor: 47.728

Review 4.  Proximal events in Wnt signal transduction.

Authors:  Stephane Angers; Randall T Moon
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07       Impact factor: 94.444

5.  Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor.

Authors:  S Confalonieri; M Quarto; G Goisis; P Nuciforo; M Donzelli; G Jodice; G Pelosi; G Viale; S Pece; P P Di Fiore
Journal:  Oncogene       Date:  2009-06-22       Impact factor: 9.867

6.  The genomic landscapes of human breast and colorectal cancers.

Authors:  Laura D Wood; D Williams Parsons; Siân Jones; Jimmy Lin; Tobias Sjöblom; Rebecca J Leary; Dong Shen; Simina M Boca; Thomas Barber; Janine Ptak; Natalie Silliman; Steve Szabo; Zoltan Dezso; Vadim Ustyanksky; Tatiana Nikolskaya; Yuri Nikolsky; Rachel Karchin; Paul A Wilson; Joshua S Kaminker; Zemin Zhang; Randal Croshaw; Joseph Willis; Dawn Dawson; Michail Shipitsin; James K V Willson; Saraswati Sukumar; Kornelia Polyak; Ben Ho Park; Charit L Pethiyagoda; P V Krishna Pant; Dennis G Ballinger; Andrew B Sparks; James Hartigan; Douglas R Smith; Erick Suh; Nickolas Papadopoulos; Phillip Buckhaults; Sanford D Markowitz; Giovanni Parmigiani; Kenneth W Kinzler; Victor E Velculescu; Bert Vogelstein
Journal:  Science       Date:  2007-10-11       Impact factor: 47.728

7.  Wnt signalling regulates adult hippocampal neurogenesis.

Authors:  Dieter-Chichung Lie; Sophia A Colamarino; Hong-Jun Song; Laurent Désiré; Helena Mira; Antonella Consiglio; Edward S Lein; Sebastian Jessberger; Heather Lansford; Alejandro R Dearie; Fred H Gage
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

8.  Comprehensive molecular characterization of human colon and rectal cancer.

Authors: 
Journal:  Nature       Date:  2012-07-18       Impact factor: 49.962

9.  The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis.

Authors:  Zhenyue Hao; Gordon S Duncan; Yu-Wen Su; Wanda Y Li; Jennifer Silvester; Claire Hong; Han You; Dirk Brenner; Chiara Gorrini; Jillian Haight; Andrew Wakeham; Annick You-Ten; Susan McCracken; Andrew Elia; Qinxi Li; Jacqui Detmar; Andrea Jurisicova; Elias Hobeika; Michael Reth; Yi Sheng; Philipp A Lang; Pamela S Ohashi; Qing Zhong; Xiaodong Wang; Tak W Mak
Journal:  J Exp Med       Date:  2012-01-02       Impact factor: 14.307

10.  Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma.

Authors:  Marios Giannakis; Xinmeng Jasmine Mu; Sachet A Shukla; Zhi Rong Qian; Ofir Cohen; Reiko Nishihara; Samira Bahl; Yin Cao; Ali Amin-Mansour; Mai Yamauchi; Yasutaka Sukawa; Chip Stewart; Mara Rosenberg; Kosuke Mima; Kentaro Inamura; Katsuhiko Nosho; Jonathan A Nowak; Michael S Lawrence; Edward L Giovannucci; Andrew T Chan; Kimmie Ng; Jeffrey A Meyerhardt; Eliezer M Van Allen; Gad Getz; Stacey B Gabriel; Eric S Lander; Catherine J Wu; Charles S Fuchs; Shuji Ogino; Levi A Garraway
Journal:  Cell Rep       Date:  2016-10-18       Impact factor: 9.423

View more
  18 in total

Review 1.  Targeting the turnover of oncoproteins as a new avenue for therapeutics development in castration-resistant prostate cancer.

Authors:  Shan Wang; Dede N Ekoue; Ganesh V Raj; Ralf Kittler
Journal:  Cancer Lett       Date:  2018-09-11       Impact factor: 8.679

Review 2.  Colorectal cancer: genetic abnormalities, tumor progression, tumor heterogeneity, clonal evolution and tumor-initiating cells.

Authors:  Ugo Testa; Elvira Pelosi; Germana Castelli
Journal:  Med Sci (Basel)       Date:  2018-04-13

3.  Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.

Authors:  Huairui Yuan; Ni Li; Da Fu; Jiale Ren; Jingyi Hui; Junjie Peng; Yongfeng Liu; Tong Qiu; Min Jiang; Qiang Pan; Ying Han; Xiaoming Wang; Qintong Li; Jun Qin
Journal:  J Clin Invest       Date:  2017-08-21       Impact factor: 14.808

Review 4.  The roles of E3 ligases in Hepatocellular carcinoma.

Authors:  Zongdong Yu; Hong Li; Jie Zhu; Haibiao Wang; Xiaofeng Jin
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

5.  Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.

Authors:  Pedram Argani; Satish K Tickoo; Andres Matoso; Christine A Pratilas; Rohit Mehra; Maria Tretiakova; Mathilde Sibony; Alan K Meeker; Ming-Tseh Lin; Victor E Reuter; Jonathan I Epstein; Jeffrey Gagan; Doreen N Palsgrove
Journal:  Am J Surg Pathol       Date:  2022-02-21       Impact factor: 6.298

6.  USP20 positively regulates tumorigenesis and chemoresistance through β-catenin stabilization.

Authors:  Chenming Wu; Kuntian Luo; Fei Zhao; Ping Yin; Ying Song; Min Deng; Jinzhou Huang; Yuping Chen; Lei Li; SeungBaek Lee; JungJin Kim; Qin Zhou; Xinyi Tu; Somaira Nowsheen; Qifeng Luo; Xiumei Gao; Zhenkun Lou; Zhongmin Liu; Jian Yuan
Journal:  Cell Death Differ       Date:  2018-06-04       Impact factor: 15.828

7.  Ubiquitylation of MYC couples transcription elongation with double-strand break repair at active promoters.

Authors:  Theresa Endres; Daniel Solvie; Jan B Heidelberger; Valentina Andrioletti; Apoorva Baluapuri; Carsten P Ade; Matthias Muhar; Ursula Eilers; Seychelle M Vos; Patrick Cramer; Johannes Zuber; Petra Beli; Nikita Popov; Elmar Wolf; Peter Gallant; Martin Eilers
Journal:  Mol Cell       Date:  2021-01-15       Impact factor: 17.970

8.  Identifying the substrate proteins of U-box E3s E4B and CHIP by orthogonal ubiquitin transfer.

Authors:  Karan Bhuripanyo; Yiyang Wang; Xianpeng Liu; Li Zhou; Ruochuan Liu; Duc Duong; Bo Zhao; Yingtao Bi; Han Zhou; Geng Chen; Nicholas T Seyfried; Walter J Chazin; Hiroaki Kiyokawa; Jun Yin
Journal:  Sci Adv       Date:  2018-01-03       Impact factor: 14.136

9.  HUWE1 controls the development of non-small cell lung cancer through down-regulation of p53.

Authors:  Dong Yang; Daomei Cheng; Qiu Tu; Huihui Yang; Bin Sun; Lanzhen Yan; Hongjuan Dai; Jierong Luo; Bingyu Mao; Yi Cao; Xiaoping Yu; Hua Jiang; Xudong Zhao
Journal:  Theranostics       Date:  2018-06-06       Impact factor: 11.556

Review 10.  The Roles of ROS in Cancer Heterogeneity and Therapy.

Authors:  Paulo Luiz de Sá Junior; Diana Aparecida Dias Câmara; Allan Saj Porcacchia; Pâmela Maria Moreira Fonseca; Salomão Doria Jorge; Rodrigo Pinheiro Araldi; Adilson Kleber Ferreira
Journal:  Oxid Med Cell Longev       Date:  2017-10-16       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.